Novocat Farma

Novocat Farma is a private pharmaceutical company based in Barcelona, Spain, focused on the development and licensing of pharmaceutical products, particularly generics. Established in 1983 by Dra. Adriana Rizzo, the company has experienced rapid growth, positioning itself as one of the fastest-growing pharmaceutical companies in Spain. With a robust portfolio of generic and new products, Novocat has emerged as one of the largest generic development companies in Europe, with an annual development pipeline of twenty generic molecules. Their in-house products are registered in major EU markets and licensed to pharmaceutical companies worldwide. One of their key strengths lies in their cost-efficient development and production processes, as well as their customer service. The company operates in compliance with Good Manufacturing Practice (GMP) standards in Europe, ensuring high-quality production. Through strategic partnerships and licensing agreements, Novocat has expanded its international presence to over 30 countries worldwide, including all EU states. This expansion is attributed to the talent and dedication of their employees, who align their goals with the needs of customers and partners, adapting to the unique requirements of each market. In addition to their international activities, Novocat is also investing in the production of value-added healthcare products in the local market, offering a diverse portfolio of in-house products for licensing. With a focus on Biotechnology and E-Commerce, the company shows potential for further growth and impact in the pharmaceutical industry.